RA Capital Management »

Health Catalyst shares owned by RA Capital Management

Quarter-by-quarter ownership of Health Catalyst (HCAT) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Health Catalyst

Tip: Access up to 7 years of quarterly data

All positions including Health Catalyst held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Health Catalyst by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9M 794k 2.39

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Cidara Therapeutics SH (CDTX)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Vaxcyte SH (PCVX)
Sionna Therapeutics SH (SION)
Newamsterdam Pharma Co Nv SH (NAMS)
Tyra Biosciences SH (TYRA)
Wave Life Sciences SH (WVE)
Mineralys Therapeutics SH (MLYS)
Edgewise Therapeutics SH (EWTX)
Septerna SH (SEPN)
Nuvalent Inc-a SH (NUVL)
Disc Medicine SH (IRON)
Janux Therapeutics SH (JANX)

View all positions for RA Capital Management

Top funds holding Health Catalyst

First Light Asset Management
BlackRock
Vanguard Group
Whetstone Capital Advisors
Impax Asset Management Group
Nepsis Capital Management
Geode Capital Management
Dimensional Fund Advisors
State Street Corporation
Palogic Value Management
Millennium Management
Kennedy Capital Management
Acadian Asset Management
RA Capital Management
HighMark Wealth Management

View all funds holding Health Catalyst